Linkage Biosciences

About:

Linkage Biosciences develops and commercializes products that improve and accelerate complex genetic testing.

Website: http://www.linkagebio.com

Twitter/X: LinkageBio

Top Investors: Greenhouse Capital Partners, Big Sky Partners, Fisher Capital

Description:

Linkage Biosciences is a molecular diagnostics company developing products that hope to improve and expedite complex genetic testing. Their initial focus is on diagnostic products for solid organ and hematopoietic stem cell transplantation where their proprietary technology will have an impact. The company offers human leukocyte antigen testing products used in solid organ and hematopoietic stem cell transplantation, as well as provides pharmacogenomic and autoimmune disease testing and research and genetic marker tests. Lingkage Biosciences was founded in 2004 and is based in

Total Funding Amount:

$12.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2004-01-01

Contact Email:

sales(AT)linkagebio.com

Founders:

Zachary C. Antovich

Number of Employees:

11-50

Last Funding Date:

2013-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai